News

Tommaso Volpi, MD, PhD, associate research scientist in radiology and biomedical imaging, has been named to the 2026 Ones to Watch list of the Society of Nuclear Medicine & Molecular Imaging (SNMMI).

Listen to the BackTable Vascular & Interventional Podcast on Techniques & Outcomes of Portal Vein Embolization with Dr. David Madoff, MD, professor of radiology & biomedical imaging and medical and surgical oncology, Yale School of Medicine; and Dr. Michael Barraza.

Hilary Blumberg, MD, left, and Christine Cha, PhD, right, are among the leading experts participating in an effort to help define the neurocognitive and psychosocial factors underlying the heightened risk of serious mental health challenges and suicide in neurodivergent young people.

Rajiv Radhakrishman, MD, senior author, and several Yale colleagues collaborated on a study published in Molecular Psychiatry that measured synaptic connections in the brain to better understand the biology of schizophrenia.

“The development of a novel PET radiotracer for the M1 receptor provided a unique opportunity to directly measure M1 receptor availability in the living brain,” explains co-lead investigator Deepak C. D’Souza, MBBS, MD, Department of Psychiatry, Yale University School of Medicine; Psychiatry Service, VA Connecticut Healthcare System; and Abraham Ribicoff Research Facilities, Connecticut Mental Health Center. “The study’s findings were robust across multiple methods of PET quantification and remained significant after accounting for potential confounding factors, including gray matter differences and partial-volume effects” says co-first author Tommaso Volpi, MD, PhD, Associate Research Scientist in Radiology and Biomedical Imaging, Yale University School of Medicine.

With liver cancer on the rise, researchers are turning to artificial intelligence to assist in the treatment of patients.

Anahita Bassir Nia, MD, assistant professor of psychisatry, has received an R01 award from the National Institute on Drug Abuse to investigate cannabinoid receptor type 1 availability in individuals with opioid use disorder.

Hyunjae Kim has been awarded one year of support through the 2026 YBII Postdoctoral Funding Program.

This summer, we saw a first-of-its-kind cross-sector collaboration – a leader in academic research and a national women’s health nonprofit joined forces to amplify the power of women’s health research and investment. The collaborative symposium “From Discovery to Impact: Accelerating Women's Health Research Through Science, Policy, and Investment” hosted by Women’s Health Research at Yale and the Society for Women’s Health Research (SWHR) on June 15 in New Haven, Conn., welcomed more than 50 speakers, researchers from 28 departments across Yale, and gathered 350+ attendees for a day-long event that covered the power of women’s health research through an arc of discovery to practical impact.